Physician profile
Ryan S Casey
NPI 1043695463
$4,623.36
in general payments reported to CMS, 2019-2025
28 companies · $675 in 2025
The $675 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $219 · 2022: $329 · 2023: $1,595 · 2024: $1,806 · 2025: $675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,316 · Travel and Lodging: $1,660 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,316.30 |
| Travel and Lodging | $1,659.51 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,149.40 | 2024 | Urolift |
| Intuitive Surgical, INC. | $834.81 | 2023 | Da Vinci Surgical System |
| Astellas Pharma US INC | $588.06 | 2021-2025 | Xtandi, Veozah |
| Antares Pharma, INC. | $496.94 | 2023-2025 | Xyosted, Tlando |
| Pfizer INC. | $283.77 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $226.74 | 2024-2025 | Orgovyx, Gemtesa |
| Seagen INC. | $99.99 | 2025 | |
| Verity Pharmaceuticals INC. | $98.03 | 2024-2025 | Tlando, Trelstar |
| Axonics, INC. | $90.17 | 2023 | Axonics |
| Coloplast Corp | $66.90 | 2023-2025 | Altis, Speedicath |
| Abbvie INC. | $66.42 | 2021-2022 | |
| Urovant Sciences INC | $60.46 | 2022 | |
| Becton, Dickinson and Company | $59.21 | 2024 | Arista Ah Flexitip |
| Convatec INC. | $57.67 | 2024-2025 | |
| Dendreon Pharmaceuticals LLC | $56.96 | 2025 | Provenge |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $54.72 | 2023 | |
| Sagent Pharmaceuticals | $41.39 | 2025 | Glydo |
| Janssen Biotech, INC. | $40.94 | 2023-2024 | Erleada |
| Myovant Sciences INC. | $40.05 | 2022 | |
| Laborie Medical Technologies Corp. | $34.43 | 2023 | |
| Depuy Synthes Sales INC. | $30.78 | 2023 | Dynacord |
| 180 Medical, INC. | $29.59 | 2025 | |
| Urogen Pharma, INC. | $24.92 | 2023 | Jelmyto |
| Novartis Pharmaceuticals Corporation | $24.20 | 2021 | |
| Sun Pharmaceutical Industries INC. | $19.01 | 2024 | |
| Olympus America INC. | $18.28 | 2023 | Itind System |
| Merck Sharp & Dohme LLC | $15.94 | 2022 | |
| Boston Scientific Corporation | $13.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Casey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.